During the past decade, Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 10 clinical trials were completed, i.e. on average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "ViiV Healthcare" with 2 trials as a collaborator, "Dynavax Technologies Corporation" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "International Maternal Pediatric Adolescent AIDS Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS" are "HIV Infections" (12 trials), "Tuberculosis" (4 trials), "HIV" (2 trials), "Hepatitis B" (2 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS" in a lesser frequency.

Most popular intervention types in "Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS" are "Drug" (15 trials), "Dietary Supplement" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Isoniazid (INH)" (3 trials), "Placebo" (2 trials), "Rifapentine (RPT)" (2 trials), "Abacavir (ABC)/Dolutegravir (DTG)/Lamivudine (3TC) Dispersible Tablets" (1 trials) and "Abacavir (ABC)/Dolutegravir (DTG)/Lamivudine (3TC) Immediate Release Tablets (Immediate release)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS" are 14 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS, 5 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".